FlexMax: A product combining BPC-157 and Epicatechin, aimed at supporting recovery for active individuals
S., Moore, C., Hersh, T
Many people taking tirzepatide wonder whether fasting is safe or beneficial during their weight loss journey
More is not always better, especially in the world of peptides where the bodys signaling systems are incredibly sensitive
This makes it a combinatorial tool of choice for protocols testing synergy with: GIPR agonists (deconstructed tirzepatide, or dedicated GIPR molecules) to explore additive incretin effects FGF21 modulators to study hepatic metabolic synergy SGLT2 inhibitors (empagliflozin, dapagliflozin) to model cardio-renal combinations observed clinically MC4R antagonists to dissect the role of the melanocortin circuit in the central anorexigenic effect Exogenous leptin (in ob/ob) to map leptin-GLP-1 crosstalk in appetite control Synergy studies must plan a 2x2 factorial design (vehicle, compound A alone, compound B alone, combination) to allow statistical interaction analysis
Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T, Parkinson Study Group-PROGENI Investigators (2009) Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
